MAOB and Alzheimer disease: Vafidemstat (ORY-2001) (Figure 18), an oral, brain penetrating, dual KDM1A/MAO-B inhibitor active at doses suitable for long-term treatment, corrects memory deficit in the Senescence Accelerated Mouse Prone 8 (SAMP8) model for accelerated aging and Alzheimer′s disease.